RxDoctor Payments Data

Tanner Fullmer

Otolaryngology · Milwaukee, WINPI 1285028753

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medical Device Business Services, Inc. at 39.6% of the total. Among otolaryngology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,347in general payments, 2019–2025

Across 86 payments — averaging $62.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • GSK$797
  • Acclarent, Inc$405
  • Optinose US, Inc.$336
  • Inspire Medical Systems, Inc.$330
  • Sanofi$291
  • plus $1K from 5 others

What the payments were for

  • Travel & lodging$2,04938%
  • Food & beverage$2,99156%
  • Education$3036%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,347 in reported general payments places this provider in the 90th percentile of 168 otolaryngology providers in Wisconsin.

See all otolaryngology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$49,913
Medicare patients
301
Services billed
642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide52$1,340
Nystatin27$471
Azelastine Hcl18$471
Doxycycline Monohydrate18$467
Fluticasone Propionate25$446
Mupirocin47$445
Pantoprazole Sodium42$254
Famotidine16$180
Fluconazole15$175
Cephalexin18$132
Levothyroxine Sodium12$115
Prednisone29$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →